Description

Sensitivity analyses confirm the robustness of the primary findings on curcumin for ulcerative colitis. Excluding individual studies did not substantially alter the pooled effect estimates.

Figure 14

Forest Plot

Source Paper

The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.

Nutrients (2020)

PMID: 32751776

DOI: 10.3390/nu12082296

Cite This Figure

![Figure 14: Sensitivity analyses confirm the robustness of the primary findings on curcumin for ulcerative colitis. Excluding individual studies did not substantially alter the pooled effect estimates.]()

> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)

<figure>
  <img src="" alt="Sensitivity analyses confirm the robustness of the primary findings on curcumin for ulcerative colitis. Excluding individual studies did not substantially alter the pooled effect estimates." />
  <figcaption>Figure 14. Sensitivity analyses confirm the robustness of the primary findings on curcumin for ulcerative colitis. Excluding individual studies did not substantially alter the pooled effect estimates.<br>  Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption>
</figure>

Related Evidence

Curcumin for Ulcerative Colitis (UC)

Grade B · 5 studies

Curcumin for Crohn's Disease

Grade C · 3 studies